Issues in the interpretation of breast core biopsies

International Journal of Surgical Pathology

Volumn 11, Issue 3, 2003, Pages 167-176

  Shousha, Sami ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Atypical hyperplasia; Breast; Breast carcinoma; Core biopsy; DCIS; LCIS

Indexed keywords

ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CALCIFICATION; BREAST TUMOR; CANCER SCREENING; CYTOLOGY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HYPERPLASIA; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0042745591     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690301100303     Document Type: Review

References (55)

1. Liberman L, Evans WP III, Dershaw DD, Hann LE, Deutch BM, Abramson AF, Rosen PP. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 190:223-225, 1994
2. Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gauge breast biopsy: How many core biopsy specimens are needed. Radiology 192:793-795, 1994
3. Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR 172:683-687, 1999
4. Grimes MM, Karageorge LS, Hogge JP. Does exhaustive search for microcalcifications improve diagnostic yield in stereotactic core needle breast biopsies? Mod Pathol 14:350-353, 2001
5. Dahlstrom JE, Sutton S, Jain S. Histologic-radiologic correlation of mammographically detected microcalcification in stereotactic core biopsies. Am J Surg Pathol 22:256-259, 1998
6. Tornos C, Silva E, El-Naggar A, Pritzker KPH. Calcium oxalate crystals in breast biopsies. The missing microcalcifications. Am J Surg Pathol 14:961-968, 1990
7. Gonzalez JEG, Caldwell RG, Valaitis J. Calcium oxalate crystals in the breast. Pathology and significance. Am J Surg Pathol 15:586-591, 1991
8. Truong LD, Cartwright J Jr, Alpert L. Calcium oxalate in breast lesions biopsied for calcification detected in screening mammography: Incidence and clinical significance. Mod Pathol 5:146-152, 1992
9. Singh N, Theaker JM. Calcium oxalate crystals (Weddellite) within the secretions of ductal carcinoma in situ - a rare phenomenon. J Clin Pathol 52:145-146, 1999
10. Martin HM, Bateman AC, Theaker JM. Calcium oxalate (Weddellite) crystals within ductal carcinoma in situ. J Clin Pathol 52:932, 1999
11. Denley H, Pinder SE, Elston CW, Lee AHS, Ellis IO. Needle core biopsy of the breast. Curr Diagn Pathol 6:200-205, 2000
12. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23:1095-1097, 1992
13. Umlas J. Gynecomastia-like lesions in the female breast. Arch Pathol Lab Med 124:844-847, 2000
14. Selland D-L G, Korbin CD, Lester SC, Lerner MH, Gulizia JA, Kaelin CM, Meyer JE. Gynecomastoid hyperplasia: Imaging findings in six patients. Radiology 214:553-555, 2000
15. Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, Dupont WD. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer 92:30-36, 2001
16. Rosenfield Darling ML, Smith DN, Lester SC, Kaelin C, Selland D-L G, Denison CM, DiPiro PJ, Rose DI, Rhei E, Meyer JE. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision. AJR 175:1341-1346, 2000
17. Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia. A probabilistic approach to reporting. Am J Surg Pathol 25:1017-1021, 2001
18. Liberman L, Dershaw DD, Glassman JR, Abramson AF, Morris EA, La Trenta LR, Rosen PP. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 203:151-157, 1997
19. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37:232-240, 2000
20. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA. Use of keratin 34 BetaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal-type benign and malignant intraductal proliferations. Am J Surg Pathol 23:1048-1058, 1999
21. Fraser, JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions. A spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22:1521-1527, 1998
22. Liberman L, Bracero N, Vuolo MA, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Percutaneous large-core biopsy of papillary breast lesions. AJR 172:331-337, 1999
23. Reynolds HE. Core needle biopsy of challenging benign breast conditions: A comprehensive literature review. AJR 174:1245-1250, 2000
24. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: Clinical importance. Radiology 216:831-837, 2000
25. Mercado CL, Hamele-Bena D, Singer C, Koenigsberg T, Pile-Spellman E, Higgins H, Smith SJ. Papillary lesions of the breast: Evaluation with stereotactic directional vacuum-assisted biopsy. Radiology 221:650-655, 2001
26. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24:1050-1056, 2000
27. Vos CBJ, Cleton-Jansen AM, Berx G, de Leeuw WJF, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis. Br J Cancer 76:1131-1133, 1997
28. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85-98, 2001
29. Georgina-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: Radiologic-pathologic correlation. AJR 176:1255-1259, 2001
30. Gabriel H. The dilemma of lobular carcinoma in situ at percutaneous biopsy: To excise or to monitor. AJR 173:300-302, 1999
31. Liberman L, Sama M, Susnik B, Rosen PP, La Trenta LR, Morris EA, Abramson AE, Dershaw DD. Lobular carcinoma in situ at percutaneous breast biopsy: Surgical biopsy findings. AJR 173:291-299, 1999
32. Berg WA, Mrose HE, Loffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core needle breast biopsy. Radiology 218:503-509, 2001
33. Jimenez RE, Bongers S, Bouwman D, Segel M, Visscher DW. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Am J Surg Pathol 24:123-128, 2000
34. Dadmanesh F, Peterse JL, Sapino A, Fonelli A, Eusebi V. Lymphoepithelioma-like carcinoma of the breast: Lack of evidence of Epstein-Barr virus infection. Histopathology 38:54-61, 2001
35. Naidoo P, Chetty R. Lymphoepithelioma-like carcinoma of the breast with associated sclerosing lymphocytic lobulitis. Arch Pathol Lab Med 125:669-672, 2001
36. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, Coscia JL Jr, Eklund GW, Evans WP III, Garver PR, Gramm HF, Haas DK, Jacob KM, Kelly KM, Killebrew LK, Lechner MC, Perlman SJ, Smid AP, Tabar L, Taber FE, Wynn RT. Percutaneous large-core breast biopsy: A multi-insitutional study. Radiology 193:359-364, 1994
37. Berna JD, Nieves FJ, Romero T, Arcas I. A multimodality approach to the diagnosis of breast hamartomas with atypical mammographic appearance. Breast J 7:2-7, 2001
38. Revelon G, Sherman ME, Gatewood OMB, Brem RF. Focal fibrosis of the breast: Imaging characteristics and histopathologic correlation. Radiology 216:255-259, 2000
39. Dahlstrom JE, Sutton S, Jain S. Histological precision of stereotactic cor biopsy in diagnosis of malignant and premalignant breast lesions. Histopathology 28:537-541, 1996
40. Denley H, Pinder SE, Elston CW, Lee AHS, Ellis IO. Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol 54:20-24, 2001
41. Zidan A, Christie Brown JS, Peston D, Shousha S. Oestrogen and progesterone receptor assessment in core biopsy specimen of breast carcinoma. J Clin Pathol 50:27-29, 1997
42. Shousha S, Peston D. Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma. Curr Diagn Pathol 4:176-180, 1997
43. Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R and the Austrian Breast & Colorectal Cancer Study Group. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7:1669-1675, 2001
44. Rosenblatt R, Fineberg SA, Sparano JA, Kaleya RN. Stereotactic core needle biopsy of multiple sites in the breast: Efficacy and effect on patient care. Radiology 201:67-70, 1996
45. Liberman L, Dershaw DD, Rosen PP, Morris EA, Cohen MA, Abramson AF. Core needle biopsy of synchronous ipsilateral breast lesions: Impact on treatment. AJR 166:1429-1432, 1996
46. Tavassoli FA, Pestaner JP. Pseudoinvasion in intraductal carcinoma. Mod Pathol 8:380-383, 1995
47. Youngson BJ, Cranor M, Rosen PP. Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896-903, 1994
48. Youngson BJ, Liberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103:598-602, 1995
49. Liberman L, Vuolo M, Dershaw DD, Morris EA, Abramson AF, LaTrenta LR, Polini NM, Rosen PP. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR 172:677-681, 1999
50. Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR 173:1303-1313, 1999
51. Liberman L, Zakowski M, Avery S, Hudis C, Morris EA, Abramson AF, LaTrenta LR, Glassman JR, Dershaw DD. Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: How can tumor size be assessed? AJR 173:1315-1322, 1999
52. Jackman RJ, Marzoni FA, Nowels KW. Percutaneous removal of benign mammographic lesions: Comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques. AJR 171:1325-1330, 1998
53. Liberman L. Percutaneous imaging-guided core breast biopsy: State of the art at the millennium. AJR 174:1191-1199, 2000
54. Mullen DJ, Eisen RN, Newman RD, Perrone PM, Wilsey JC. The use of carbon marking after stereotactic large-core-needle breast biopsy. Radiology 218:255-260, 2001
55. Fine RE, Israel PZ, Walker LC, Corgan KR, Greenwald LV, Berenson JE, Boyd BA, Oliver MK, McClure T, Elberfeld J. A prospective study of the removal rate of imaged breast lesions by an 11-gauge vacuum-assisted biopsy probe system. Am J Surg 182:335-340, 2001